Development of a Standardized Scoring System to Assess a Murine Model of Clostridium difficile Colitis.

J Invest Surg 2019 Mar 20:1-9. Epub 2019 Mar 20.

a Center for Perinatal Research, The Research Institute at Nationwide Children's Hospital, Department of Pediatric Surgery , Nationwide Children's Hospital , Columbus , OH , USA.

Background: Clostridium difficile infection is the most common cause of antimicrobial-associated diarrhea. Our aim was to introduce a novel and efficient clinical sickness score (CSS), and to define a detailed histologic injury score (HIS) in a murine model of C. difficile colitis.

Methods: Mice received an antibiotic cocktail (kanamycin, gentamicin, colistin, metronidazole, and vancomycin) for 96 h. After 48 h, mice received an intraperitoneal injection of clindamycin, followed by oral C. difficile (1.5 × 10 CFU). Signs of sickness were scored using a novel CSS (range 0-12) with scores ≥6 consistent with C. difficile colitis. Intestinal tissue was analyzed utilizing an adapted HIS (range 0-9) with scores ≥4 consistent with C. difficile colitis. Stool was analyzed for C. difficile, and survival evaluated.

Results: No control mice showed signs of sickness, whereas 23% of mice receiving antibiotics alone and 65% of mice exposed to antibiotics and subsequently C. difficile demonstrated signs of sickness (p = 0.0134). No control mice had histologic injury, whereas 8% of mice receiving antibiotics alone and 75% of mice exposed to antibiotics followed by C. difficile had evidence of histologic injury (p = 0.0001). Mice exposed to C. difficile lost more weight, although not significant (p = 0.070). Mice that received C. difficile had decreased survival compared to control mice and mice receiving antibiotics only (p = 0.03).

Conclusions: We have developed a novel clinical scoring system, and detailed histological grading system, that enables the objective evaluation of a murine C. difficile colitis model. This model allows the study of this disease in a host that demonstrates clinical and histologic signs comparable to human C. difficile infection. This will allow for improved study of therapeutics for this disease in the future.

Download full-text PDF

Source
http://dx.doi.org/10.1080/08941939.2019.1571129DOI Listing
March 2019
28 Reads

Publication Analysis

Top Keywords

difficile colitis
16
difficile
13
signs sickness
12
mice received
12
mice receiving
12
mice exposed
12
control mice
12
receiving antibiotics
12
mice
12
histologic injury
12
difficile infection
8
exposed antibiotics
8
clostridium difficile
8
scoring system
8
consistent difficile
8
murine model
8
antibiotics
5
65% mice
4
antibiotics difficile
4
difficile evidence
4

References

(Supplied by CrossRef)

Czuprynski CJ et al.
Infect Immun. 1983

Knoop FC et al.
Infect Immun. 1979

Similar Publications